| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5859836cd5b65a17aa0963b145287c90 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 |
| filingDate |
2005-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d9f63f1f975574c09e9800e4017fb62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcbc61e945979fcfb035a549827c9077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac07dd893ce8c9f9eea2587f58c87c32 |
| publicationDate |
2007-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2007131542-A |
| titleOfInvention |
Stabilized cabergoline solid formulation |
| abstract |
The present invention provides a stable cabergoline oral solid preparation which does not cause a decrease in content due to decomposition of a main drug during storage. A stable oral solid preparation comprising cabergoline and mannitol and talc. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9675570-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5627062-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10561628-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015156302-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114732791-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10603285-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-6026706-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014163132-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114732791-A |
| priorityDate |
2005-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |